Stay updated on Balstilimab and Zalifrelimab in Cervical Cancer Clinical Trial
Sign up to get notified when there's something new on the Balstilimab and Zalifrelimab in Cervical Cancer Clinical Trial page.

Latest updates to the Balstilimab and Zalifrelimab in Cervical Cancer Clinical Trial page
- Check6 days agoChange DetectedNew Revision: v3.3.3 appears on the page and the HHS Vulnerability Disclosure link is removed, indicating minor UI and footer updates. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check13 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check34 days agoChange DetectedThe record history now includes a new revision v3.3.2 and removes v3.2.0, reflecting a routine update to the study's version history. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check41 days agoChange DetectedRemoved the government funding lapse notice from the page; this informational banner did not relate to the trial data or core content.SummaryDifference0.8%

- Check56 days agoChange DetectedA new version entry on 2024-03-27 was added to the study record history, noting updates to recruitment status and other study details; to avoid alerts for small changes, set an alert condition.SummaryDifference0.1%

- Check84 days agoChange DetectedUpdated operating status notice and version to v3.2.0; removed mention of v3.1.0.SummaryDifference13%

- Check91 days agoChange DetectedUpgrade applied: version updated from v3.0.2 to v3.1.0. No other substantive content changes detected.SummaryDifference0.3%

Stay in the know with updates to Balstilimab and Zalifrelimab in Cervical Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Balstilimab and Zalifrelimab in Cervical Cancer Clinical Trial page.